Yüklüyor......
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
Idarucizumab (Praxbind) is a humanized antibody fragment, that reversibly and with high affinityties up dabigatran (Pradaxa). Anticoagulation reversal is achieved immediately, and with no procoagulant effect. It is administered intravenously and clearance is renal. The main clinical application of i...
Kaydedildi:
| Yayımlandı: | Vasc Health Risk Manag |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536811/ https://ncbi.nlm.nih.gov/pubmed/31213821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S181806 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|